The FDA has cleared its first prescription digital therapeutic for patients suffering from opioid abuse: a smartphone app designed by Pear Therapeutics to be used alongside standard-of-care medication-assisted treatments.....
The draft guidelines could make it easier for new treatments to be developed, as clinical trials can be based on other patient outcomes beyond reduction in drug use.
The U.S. Food and Drug Administration today issued new scientific recommendations aimed at encouraging more widespread innovation and development of novel medication-assisted treatment (MAT) drugs for the treatment of opioid use disorder (OUD).